The Food and Drug Administration will withdraw its approval of Lannett Company Inc.'s (NYSE: LCI) generic attention deficit disorder treatment sending the stock price plummeting $3.20 to close at $21.65.
FDA withdraws approval of Lannett's ADHD drug
October 17, 2016 at 17:11 PM EDT
